MIKAN GEORGE LAWRENCE III (CEO & President) sold 9.3% of their position (7.72K shares) of NEUEHEALTH, INC. on the open market
Open‑market sale worth $59.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/13/2024ACC: 0001628280-24-011050
DirectorOfficer· CEO & President
Since Jun 2021
-7.72K
Net shares
Net seller
$59.3K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
7.72K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−2.66K
Price / share
$8.11
Trade value
$21.61K
% of position
3.2%
3/11/2024
83.39K→80.72K
Common Stock
Direct
Shares
−1.60K
Price / share
$7.76
Trade value
$12.40K
% of position
2.0%
3/12/2024
80.72K→79.13K
Common Stock
Direct
Shares
−3.46K
Price / share
$7.30
Trade value
$25.28K
% of position
4.4%
3/13/2024
79.13K→75.66K
Total
Net shares
−7.72K
Net value
-$59.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2024 | S · Sale | −2.66K | $8.11 | $21.61K | 3.2% | 83.39K | 80.72K |
| Common Stock Direct | 3/12/2024 | S · Sale | −1.60K | $7.76 | $12.40K | 2.0% | 80.72K | 79.13K |
| Common Stock Direct | 3/13/2024 | S · Sale | −3.46K | $7.30 | $25.28K | 4.4% | 79.13K | 75.66K |
| Total | −7.72K | -$59.29K | ||||||
Derivative Transactions0
No derivative transactions reported